InVitro IVRO Stock
InVitro Price Chart
InVitro IVRO Financial and Trading Overview
| InVitro stock price | 0.07 USD |
| Previous Close | 0.07 USD |
| Open | 0.08 USD |
| Bid | 0.07 USD x 6000000 |
| Ask | 0.08 USD x 1000000 |
| Day's Range | 0.07 - 0.09 USD |
| 52 Week Range | 0.03 - 0.16 USD |
| Volume | 188.62K USD |
| Avg. Volume | 11.04K USD |
| Market Cap | 1.56M USD |
| Beta (5Y Monthly) | -0.727 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IVRO Valuation Measures
| Enterprise Value | 1.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.7728086 |
| Price/Book (mrq) | 0.9459459 |
| Enterprise Value/Revenue | 1.394 |
| Enterprise Value/EBITDA | 13.339 |
Trading Information
InVitro Stock Price History
| Beta (5Y Monthly) | -0.727 |
| 52-Week Change | -17.13% |
| S&P500 52-Week Change | 13.08% |
| 52 Week High | 0.16 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.08 USD |
IVRO Share Statistics
| Avg. Volume (3 month) | 11.04K USD |
| Avg. Daily Volume (10-Days) | 37.57K USD |
| Shares Outstanding | 22.26M |
| Float | 15.25M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | September 30, 2008 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 13.87% |
| Operating Margin (ttm) | 9.90% |
| Gross Margin | 81.69% |
| EBITDA Margin | 10.45% |
Management Effectiveness
| Return on Assets (ttm) | 2.75% |
| Return on Equity (ttm) | 7.57% |
Income Statement
| Revenue (ttm) | 878.94K USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | -12.90% |
| Gross Profit (ttm) | 718.09K USD |
| EBITDA | 91.87K USD |
| Net Income Avi to Common (ttm) | 121.98K USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | 48.79% |
Balance Sheet
| Total Cash (mrq) | 332.67K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 12.182 |
| Book Value Per Share (mrq) | 0.074 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7283 USD |
| Levered Free Cash Flow (ttm) | 89.23K USD |
Profile of InVitro
| Country | United States |
| State | CA |
| City | Placentia |
| Address | 330 East Orangethorpe Avenue |
| ZIP | 92870 |
| Phone | 800 246 8487 |
| Website | https://www.invitrointl.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
InVitro International, Inc. Develops and markets test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.
Q&A For InVitro Stock
What is a current IVRO stock price?
InVitro IVRO stock price today per share is 0.07 USD.
How to purchase InVitro stock?
You can buy IVRO shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InVitro?
The stock symbol or ticker of InVitro is IVRO.
Which industry does the InVitro company belong to?
The InVitro industry is Diagnostics & Research.
How many shares does InVitro have in circulation?
The max supply of InVitro shares is 22.26M.
What is InVitro Price to Earnings Ratio (PE Ratio)?
InVitro PE Ratio is now.
What was InVitro earnings per share over the trailing 12 months (TTM)?
InVitro EPS is 0 USD over the trailing 12 months.
Which sector does the InVitro company belong to?
The InVitro sector is Healthcare.
